Abbott Laboratories
103.70USD
+1.1900 (+1.16%)
Computing valuation metrics…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on ABT.
Valuation
P/E (TTM)
28.78x
P/E (Forward)
17.44x
EV/EBITDA
22.56x
EV/Revenue
4.59x
P/S (TTM)
4.00x
P/B
3.47x
FCF Yield
4.08%
Dividend Yield
2.43%
Gross Margin
56.26%
Operating Margin
17.07%
Net Margin
13.91%
Peer Comparison — Medical Devices
| Company | Mkt Cap | P/E | EV/EBITDA | FCF Yield | Rev Growth | Div Yield |
|---|---|---|---|---|---|---|
| ABTAbbott Laboratories | $180.63B | 28.78x | 22.56x | 4.08% | 7.78% | 2.43% |
| MDTMedtronic plc | $122.04B | 23.44x | 13.64x | 4.43% | 13.70% | 3.02% |
Subject metrics from SEC filings where available; peer metrics from cached market data.
| $117.81B |
| 31.83x |
| 17.60x |
| 3.49% |
| 9.40% |
| 1.15% |
| BSXBoston Scientific Corporation | $66.22B | 18.50x | 13.75x | 3.70% | 7.50% | 0.00% |
| EWEdwards Lifesciences Corporation | $51.29B | 52.09x | 23.99x | 2.40% | 13.60% | 0.00% |
| GEHCGE HealthCare Technologies Inc. | $32.50B | 16.43x | 11.40x | 4.84% | 5.80% | 0.22% |
| DXCMDexCom, Inc. | $29.41B | 30.93x | 20.57x | 3.47% | 13.10% | 0.00% |
| STESTERIS plc | $22.63B | 28.38x | 14.76x | 3.53% | 7.30% | 1.11% |
| ZBHZimmer Biomet Holdings, Inc. | $18.80B | 23.92x | 10.28x | 5.70% | 4.80% | 0.97% |